Literature DB >> 15362289

Triflupromazine: a microbicide non-antibiotic compound.

Sujata G Dastidar1, Sanchayita Debnath, Kaushiki Mazumdar, Kumkum Ganguly, A N Chakrabarty.   

Abstract

The antipsychotic phenothiazine triflupromazine, possessing a methyl-thio substituent at position 10 and a fluorine moiety at position 2, exhibited significant antibacterial activity against 279 strains of Gram-positive and Gram-negative bacteria. The minimum inhibitory concentration (MIC) of the drug, according to the agar dilution method, was between 2 and 50 microg/ml for Staphylococcus aureus, and 5 and 100 microg/ml for shigellae and vibrios. Triflupromazine, when injected intraperitoneally into Swiss albino mice at a concentration of 30 microg/mouse (20 g), manifested a significant protection to the mice (p<0.001) when they were challenged with 50 median lethal dose (MLD) of Salmonella typhimurium NCTC 74. Moreover, there was a statistically significant reduction in the number of viable bacteria in organ homogenates and blood of mice treated with this phenothiazine compound.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362289

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  4 in total

1.  Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

Authors:  L Jeyaseeli; A Dasgupta; S G Dastidar; J Molnar; L Amaral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

Review 2.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.

Authors:  Hassan Nehme; Patrick Saulnier; Alyaa A Ramadan; Viviane Cassisa; Catherine Guillet; Matthieu Eveillard; Anita Umerska
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

4.  A comparative analysis of in vitro and in vivo efficacies of the enantiomers of thioridazine and its racemate.

Authors:  Jørn B Christensen; Oliver Hendricks; Shaswati Chaki; Sayanti Mukherjee; Ayan Das; Tapan K Pal; Sujata G Dastidar; Jette E Kristiansen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.